GGrantIndex
Sort

326,823 grants matching clinical trial

Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation

$1,699,475
David Neal Fredricks · Fred Hutchinson Cancer Center · R01 · FY2023 · HL

Type 1 Diabetes TrialNet Clinical Network Hub

$1,699,459
Carla J Greenbaum · Benaroya Research Inst At Virginia Mason · U01 · FY2018 · DK

A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies

$1,699,322
Jing Zhou · Isoplexis, Inc. · R44 · FY2019 · CA

AIDS CLINICAL TRIALS UNIT

$1,699,170
Harvard University (Medical School) · U01 · FY2002 · AI

SBIR Phase II: Medical Device for Monitoring Respiratory Disease

$1,699,135
Justice Amoh · Clairways Llc · · FY2021 · TIP

CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS

$1,699,083
George Mitra · Leidos Biomedical Research, Inc. · N01 · FY2022 · CA

CircuLite's Circulatory Support System in Children and Infants

$1,698,956
Gail G Farnan · Circulite, Inc. · R44 · FY2010 · HL

Global Network for Women's and Children's Health Research Data Coordinating Center

$1,698,618
Elizabeth M McClure · Research Triangle Institute · U24 · FY2023 · HD

Transplantation Group

$1,698,563
Michelle Lynn Sever · Rho Federal Systems Division, Inc. · UM2 · FY2021 · AI

Kidney transplant Preemptive therapy or Prophylaxis (KPoP) for CMVPreventionin D+R- Recipients

$1,698,522
Abhijit Prakash Limaye · University Of California, San Francisco · R01 · FY2025 · AI

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$1,698,499
Mary L. Disis · University Of Washington · UL1 · FY2009 · RR

Adult Brain Tumor Consortium (ABTC)

$1,698,364
Stuart A Grossman · Johns Hopkins University · U01 · FY2013 · CA

Develop and Validate a Mouse Model for Alzheimer Disease in Down Syndrome

$1,698,323
William C Mobley · University Of California, San Diego · R61 · FY2024 · NS

Molecular approaches to understand vector-host and vector-pathogen interactions

$1,698,242
Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Informed Combination Strategies for Peripheral T-cell Lymphomas

$1,698,229
Birgit Knoechel · Dana-Farber Cancer Inst · P01 · FY2023 · CA

Informed Combination Strategies for Peripheral T-cell Lymphomas

$1,698,229
Birgit Knoechel · Dana-Farber Cancer Inst · P01 · FY2022 · CA

Carbohydrate: Amount and Type Affecting Risk for CVD and Diabetes

$1,698,198
Frank M Sacks · Brigham And Women'S Hospital · R01 · FY2007 · HL

Johns Hopkins AIDS Clinical Trials Unit

$1,698,051
Charles W. Flexner · Johns Hopkins University · UM1 · FY2012 · AI

Improving Cancer Outcome--Adaptive Helical Tomotherapy

$1,697,990
University Of Wisconsin Madison · P01 · FY2002 · CA

Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)

$1,697,961
Ruchi S Gupta · Lurie Children'S Hospital Of Chicago · U01 · FY2023 · AI

Alphavirus replicon vectors as dose-sparing adjuvants for Influenza vaccines.

$1,697,948
Jonathan Smith · Alphavax Human Vaccines, Inc. · U01 · FY2007 · AI

PACT

$1,697,931
Jason Jacobs · University Of Minnesota · N01 · FY2011 · HL

NIMH Collaborative HIV/STD Prevention Trial -- India

$1,697,756
Johns Hopkins University · U10 · FY2004 · MH

Clinical Training in Rheumatology

$1,697,705
Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIE · FY2016 · AR

HEAL: Induced Pluripotent Stem Cell (iPSC)-Derived Neurons for Pain, Addiction and Overdose

$1,697,615
Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR